iNova to acquire three ranges from Probiotec

31 August 2018 - Deborah Wilkes

Premium

iNova Pharmaceuticals has agreed to acquire a portfolio of products from Australian company Probiotec for AUD13.5 million (USD16.5 million) in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: